Urinary Excretion Rate of Antithrombin III Related Antigen in Cerebral Stroke

Summary

The urinary excretion rate of antithrombin III related antigen (AT III RA) was examined in cerebral stroke. The excretion rate of AT III RA in cerebral hemorrhage (CH) was 12.33 ± 1.61 × 10^-4 ml/min. The patients with CH were further classified into two groups: in group CH-I, whose consciousness state was stupor or further deteriorated including coma on admission, the excretion rate of AT III RA was 18.08 ± 2.50 × 10^-4 ml/min. In group CH-II, whose consciousness state was clear on admission, the excretion rate of AT III RA was significantly lower than that in CH-I (6.20 ± 1.56 × 10^-4 ml/min). The excretion rate in cerebral thrombosis (CT) was 1.96 ± 0.25 × 10^-4 ml/min, which was significantly lower than that in CH. The excretion rate of AT III RA in both CH and CT was significantly higher than that in the healthy control group (0.29 ± 0.04 × 10^-4 ml/min). Thus, AT III may change dynamically in cerebral stroke.

Key words

Antithrombin III - Excretion rate - Cerebral stroke - Sandwich immunoassay

• References

• 1 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
• 2 Mortensen JZ, Jørgensen KA. Antithrombin. Dan Med Bull 1983; 30: 100-105
• 3 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombos Diathes Haemorrh 1965; 13: 516-541
• 4 Matsuo O. Incidence of thrombosis in inherited antithrombin III deficiency. Thromb Res 1981; 24: 509-510
• 5 Tanaka M, Kato K. Determination of antithrombin III by sandwich enzymeimmunoassay. Thromb Res 1981; 22: 67-74
• 6 Miller-Anderson M, Borgh H, Andersson LO. Purification of antithrombin III by affinity chromatography. Thromb Res 1974; 5: 439-452
• 7 Collen D, De Cock F. Neoantigenic expression in enzyme-inhibitor complexes: a means to demonstrated activation of enzyme systems. Biochim Biophys Acta 1978; 525: 287-290
• 8 Kato K, Hamaguchi Y, Okawa S, Ishikawa E, Kobayashi K, Katunuma N. Use of rabbit antibody IgG-loaded silicone pieces for the sandwich enzyme-immunoassay of macromolecular antigens. J Biochem 1977; 81: 1557-1566
• 9 Guyton A. Formation of urine by the kidney. In: Textbook of Medical Physiology. W B Saunders; Philadelphia/London: 1981. p 403
• 10 Nakamura RM, Dito WR, Tucker III ES. Immunoassays. In: Clinical laboratory techniques for the 1980s. Alan R. Liss Inc; New York: 1980. p 1
• 11 Biggs R, Denson WE, Akman N, Borret R, Hadden M. Antithrombin III, antifactor Xa and heparin. Br J Haematol 1970; 19: 283-305
• 12 Heimburger N, Haupt H, Schwick HG. Proteinase inhibitors of human plasma. In: Proceedings of the International Research Conference on Proteinase Inhibitors. Fritz H, Tschesche H. (eds) Walter de Gruyter; Berlin/New York: 1971. p 1
• 13 Messmore HL. Natural inhibitors of coagulation system. Semin Thromb Hemostas 1982; 8: 267-275
• 14 Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976; 69: 209-216
• 15 Moroi M, Aoki N. Isolation and characterization of α₂-antiplasmin inhibitor from human plasma. J Biol Chem 1976; 251: 5956-5965
• 16 Hougie C, Baugh RF. Current views on blood coagulation and haemostatic mechanism. In: Blood coagulation and haemostasis. Thomsom JM. (ed) 2. Edition Churchill Livingstone; Edinburgh/ London/New York: 1980. p 1
• 17 Collen D, De Cock F, Verstraete M. Quantitation of thrombinantithrombin III complex in human blood. Eur J Clin Invest 1977; 7: 407-411
• 18 Mettinger KL, Nyman D, Kjellin KG, Sidén Å, Söderström CE. Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease. J Neurol Sci 1979; 41: 31-38
• 19 Wahlberg JB, Blombäck M, Overmark I. Blood coagulation studies in 45 patients with ischemic cerebrovascular disease and 44 patients with venous thromboembolic disease. Acta Med Scand 1980; 207: 385-390
• 20 Marra R, Pagano L, De Stefano V, Bizzi B. Antithrombin III and factor Xa inhibitor in atherosclerosis. Haemostasis 1983; 13: 209-213
• 21 Vermylen J. Physiology of haemostasis. In: Platelet: A multidisciplinary approach. De Gaetano G, Garattini S. (eds) Raven Press; New York: 1978. p 3